Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: Results from the medications applied and sustained over time (MAINTAIN) registry

American Heart Journal

Volumn 160, Issue 6, 2010, Pages

  Melloni, Chiara ^a   Shah, Bimal R ^a,b   Ou, Fang Shu ^a   Roe, Matthew T ^a   Smith Jr , Sidney C ^c   Pollack Jr , Charles V ^d   Ohman, Magnus ^a   Gibler, W Brian ^e   Peterson, Eric D ^a   Alexander, Karen P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d PENNSYLVANIA HOSPITAL   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; TREATMENT OUTCOME;

EID: 78650181817     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.09.008     Document Type: Article

References (21)

1. Pasternak RC, Brown LE, and Stone PH Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels: a randomized, placebo-controlled trial Ann Intern Med 125 1996 529 540
2. Brown AS, Bakker-Arkema RG, and Yellen L Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin J Am Coll Cardiol 32 1998 665 672
3. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
4. Cannon CP, Braunwald E, and McCabe CH Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
5. Sever PS, Dahlof B, and Poulter NR Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Lancet 361 2003 1149 1158 (Pubitemid 36398384)
6. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
7. LaRosa JC, Grundy SM, and Waters DD Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
8. American College of Cardiology/American Heart Association Task Force on Practice G Developed in Collaboration With the Canadian Cardiovascular S, Endorsed by the American Academy of Family P 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction J Am Coll Cardiol 51 2008 210 247
9. Anderson JL, Adams CD, and Antman EM ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
10. Smith SC Jr, Allen J, and Blair SN AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute J Am Coll Cardiol 47 2006 2130 2139 (Pubitemid 44275145)
11. Melloni C, Alexander KA, and Ou FS Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome Am J Cardiol 104 2009 175 181
12. Nissen SE, Tuzcu EM, and Schoenhagen P Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080 (Pubitemid 38541684)
13. Grundy SM, Cleeman JI, and Merz CN Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
14. Sacks FM, Pfeffer MA, and Moye LA The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
15. Shepherd J, Kastelein JJP, and Bittner V Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study J Am Coll Cardiol 51 2008 1448 1454 (Pubitemid 351471787)
16. de Lemos JA, Blazing MA, and Wiviott SD Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
17. Nissen SE, Nicholls SJ, and Sipahi I Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
18. Davidson MH, Maki KC, and Pearson TA Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and implications for treatment under the recent NCEP writing group recommendations Am J Cardiol 96 2005 556 563
19. Waters DD, Brotons C, and Chiang C-W Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34
20. Spencer FA, Goldberg RJ, and Gore JM Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein > = 100 mg/dl Versus <100 mg/dl Am J Cardiol 100 2007 913 918
21. Biorck G, Blomqvist G, and Sievers J Cholesterol values in patients with myocardial infarction and in a normal control group Acta Med Scand 156 1957 493 497